TNFRSF11B and breast cancer: In studies in breast cancer patients, most reported either no or an inverse association between tumor RANKL or OPG expression and risk of death [23–27], recurrence [23–25, 27, 28], and metastasis [25, 29, 30], though this was not observed in all studies [31].